105 Participants NeededMy employer runs this trial

Blood Flow Restriction Therapy for Postoperative Rehabilitation After Ankle Surgery

(BFRankle recon Trial)

Recruiting at 4 trial locations
EH
JH
Overseen ByJenny Hudnall, MS BME
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Texas Tech University Health Sciences Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this single blinded clinical trial is to investigate blood flow restriction (BFR) for rehabilitation of patients after ankle ligament reconstruction surgery. Outcome measures will be compared between the standard of care (SoC) and BFR groups at the end of the study intervention.

Following standard surgical procedures, both groups will undergo physical therapy by a certified physical therapist for a minimum of 6 weeks. The SOC group will receive standard physical therapy without use of BFR. The BFR group will receive physical therapy with BFR. Outcome measures of interest will be taken at the start of physical therapy (time 0) and at the end of physical therapy (minimum of 6 weeks of PT) for both groups.

Outcome measures of interest include:

* muscle atrophy;

* ankle function;

* fatigability/manual muscle testing;

* pain scores;

* cardiovascular effects (heart rate, blood pressure).

Who Is on the Research Team?

JG

Jerry Grimes, MD

Principal Investigator

Texas Tech University Health Sciences Center

Are You a Good Fit for This Trial?

Inclusion Criteria

I am between 18 and 65 years old.
I have had ankle ligament reconstruction surgery.
I can pay for or have insurance for at least 6 weeks of physical therapy.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Postoperative Recovery

Participants recover from ankle ligament reconstruction surgery before starting physical therapy

4 weeks

Treatment

Participants receive physical therapy with or without blood flow restriction (BFR) for rehabilitation

6 weeks
Weekly PT sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Blood Flow Restriction Therapy

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Blood flow restriction (BFR) groupExperimental Treatment1 Intervention
Group II: Standard of Care (SOC) groupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Texas Tech University Health Sciences Center

Lead Sponsor

Trials
107
Recruited
11,500+

The Center for Orthopedic Surgery

Collaborator

UMC Health System

Collaborator

H2 Health (Physical Therapy Today)

Collaborator

Northstar Surgery Center

Collaborator